Introduction
Adnexal mass refers to any mass occupying the region of uterine appendages including ovarian neoplasm, endometrioma, tubo-ovarian mass, myoma, ectopic pregnancy 1 . Ovarian tumor is the second most common gynaecologic cancer variant in developing countries causing huge mortality among women 2 . Peak incidence of epithelial ovarian cancer (EOC) is at 50-70 years subsequently declining to less than 2% after 80 years. About 30% of ovarian tumors in post menopausaland 7% in pre-menopausal are malignant 3. 95% of women with ovarian cancer have non-gynaecological symptoms like abdominal distension, bloating, constipation, nausea, anorexia, or early satiety [4] [5] [6] [7] . Standard management of EOC consists of aggressive surgical cytoreduction followed by chemotherapy. Extensive retrospective experience showed that optimal surgical debulking with no or less than 1 cm residual tumor is associated with improved patient outcome 8 . Considering diagnostic difficulties, RMI, an acronym for risk of malignancy index, was first described by Jacobs et 
Methodology
This cross-sectional descriptive study was conducted at the Department of Obstetrics and Gynaecology of ShSMCH from April 01, 2013 to September 30, 2013.Fifty women, 30-75 years, admitted with adnexal mass (diagnosed either per abdominally or sonographically) for laparotomy, were randomly selected. Those who have suspected uterine malignancy or deny surgery are excluded. After taking informed consent, menopausal status, serum CA125 level and ultrasound findings of participants were registered. If there were no bilateral lesions, multilocular cyst, solid areas, ascites and abdominal metastases on TAS, it was termed as no abnormality (U=1), if any one abnormality was found it was termed as one abnormality (U=1) and >one abnormality was named as two (U=4). Laparotomy followed by histopathological analysis of specimens were done. RMI calculation was based on a simple regression equation where premenopausal status gave M=1 and postmenopausal M=4. CA125 level was applied directly into calculation. All statistical analyses were done in SPPS inc.version 11.5. Chi-square tests were used to test difference in age distribution, menopausal status and ultrasound score. Sensitivity, Specificity, Positive
Predictive value (PPV) and Negative predictive value (NPV) were calculated for 3 cut-off values of RMI. Scoring should be carried out before laparotomy in assessing nature of mass. The best cut-off value was chosen according to the highest sensitivity with lowest false-positive rate.
Results:
Majority of the patients in this study were between 30-75 years with mean age being 40.7 years (SD 11.16 yrs) consisting of 32 (64%) pre-menopausal and 18 (36%) postmenopausal. Abdominal pain was complained by all patients followed by lump in 32 (64%), dyspepsia in 7 (14%) and constipation in 5 (10%) of patients. No abnormality on TAS was detected in 60%, one abnormality in 20% and two or more abnormalities in another 20%. 20 patients (40%) serum CA 125 fell within normal range (<35 U/ml).Pre-operative RMI value for assessment was taken as 200 and found 76% patients' RMI <200 and 24% had >200. Among 10 categories of histopathologically diagnosed masses, majority occupied two domains (28% serous cyst adenoma, 24% endometriosis). Benign conditions included: functional cysts (n=02), simple serous cyst (n=14), Dermoid cyst (n=04), Endometriosis (n=12), Mucinous cystadenoma (n=04), ectopic pregnancy (n=02) and parovarian cyst (n=04) whereas malignant tumors: Serous cystadenocarcinoma (n=2), Mucinous cystadenocarcinoma (n=2), and secondary adenocarcinoma (n=4).
Fig.-1: Pie chart showing histopathological variants of adnexal masses
Though statistically insignificant differences were found between groups with benign and malignant pathology considering age (P value 0.074), menopausal status (P value 0.004), TAS score (P value .000) and CA 125 (P value .000), it was shown that higher proportions of malignant cases were associated with higher age, US score and serum CA 125.The best performance was obtained for RMI cut-off value of 230 with sensitivity 100%, specificity 95%, PPV 80% and NPV 100%. 17,18,19. In the study 100% patients presented with abdominal pain and 64% with abdominal lump showing similar result by TayyibaWasim et al where abdominal pain was seen in 66% patients 20 . In a retrospective cohort study by Lataifeh et al with, abdominal pain and swelling were reported by 51% and 32% respectively in early stage and lump by 62% and pain by 44% in advanced stage 7 . This study do not differentiate symptoms among early and advanced cases.
In 80% cases USG revealed only unilateral adnexal mass scoring 1. All patients with U=1 had benign tumors; on the other hand, 90% of them who obtained U=4 were malignant in histopathology. Though there was a difference between these two groups (p value 0.000), it was not statistically significant. Tahereh et al 17 also showed, 98% patients with U score=1 had benign tumors with 65.4% patients with high score had malignancy and it was also statistically insignificant. Association of higher sonographic score with malignant cases was also supported by WatcharadaMoolthiya et al and Samir et al. Serum CA125 value >200 u/ml associated with malignant conditions was also supported by previous studies 17, 18 . Main limitation of serum CA125 is its high value in benign diseases such as ovarian cysts, endometriosis and pelvic infection 21 , reflected in present study. In this study out of 50 patients with adnexal mass,based on histopathological reports, less malignant cases (18%) were diagnosed than benign which is in concordance with previous studies 34, 36 .WatcharadaMoolthiya et al, stated in his study majority false positive cases were due to dermoid cysts and mucinous cyst adenomas while false negative cases were for borderline tumors, result not supported by this study 18 .
At lower cut off values sensitivity increases at the expense of specificity, while at a higher cut off values specificity increases at the expense of sensitivity and more benign cases will be referred as malignant. These findings are important for clinical applicability of RMI. In the present study sensitivity of RMI (100%) to predict malignancy was higher than those reported by the previous studies 10, 9, 17, 18, 22, 23 . One possible explanation is that we cannot differentiate early stage and borderline ovarian tumor.
Conclusion
This study demonstrated that RMI scoring is a simple and effective one in assessing nature of adnexal masses preoperatively, despite some limitations. It guides the clinicians to determine which tumors will be operated by Gynaecologists/Gynae-oncologist and thereby improves patient's outcome.
